Simon Coggins is vice president and biopharma business segment lead for hematology and oncology, PPD’s largest therapeutic unit. His role includes oversight of teams responsible for program delivery of hema- tology and oncology studies for PPD’s biopharma client partnerships. Working to bring the latest innovations and maximize clinical trial op- portunities to oncology and hematology patients through digital and decentralization, he serves as the therapeutic unit liaison with PPD Dig- ital. Coggins joined PPD in 2003 and has extensive clinical research and industry experience. He earned his doctorate in microbiology and chemistry from the University of Wales, and his bachelor’s degree from the University of Wolverhampton, both in the United Kingdom.